KalVista Pharmaceuticals(KALV) - 2026 Q1 - Earnings Call Transcript

KalVista Pharmaceuticals (NasdaqGM:KALV) Q1 2026 Earnings Call September 11, 2025 08:30 AM ET Company ParticipantsBen Palleiko - CEONicole Sweeny - CCOBrian Piekos - CFORyan Baker - Head of Investor RelationsConference Call ParticipantsSerge Belanger - AnalystNone - AnalystDevanjana Chatterjee - AnalystMaury Raycroft - AnalystStacy Koo - AnalystWilliam Dubin - AnalystPaul Matteis - Senior Biotechnology AnalystPete Stavropoulos - AnalystTazeen Ahmad - AnalystOperatorLadies and gentlemen, thank you for standi ...